Autoimmune pancreatitis (AIP) is a rare but potentially serious condition caused by the immune system of our own body attacking the healthy pancreatic cells. It is known to affect less than 1 out of 100,000 people, and it is often misdiagnosed as it mimics the symptoms of pancreatic cancer.
Jaipur is well-known for its diverse healthcare facilities and hospitals for various health conditions. Keep reading to learn about what autoimmune pancreatitis is and how it is treated in Jaipur.
Autoimmune pancreatitis (AIP) is a rare form of chronic pancreatitis that develops when the body mistakenly targets and attacks healthy pancreatic tissues, resulting in inflammation and swelling.
AIP is often associated with other autoimmune diseases and has a clinical presentation that can replicate pancreatic cancer. AIP is characterised by prolonged inflammation of the pancreas, often presenting as a single episode, though recurrence may occur in some cases.
Fortunately, autoimmune pancreatitis responds well to treatment, especially if diagnosed early. Major healthcare facilities in Jaipur offer comprehensive therapy, including:
Corticosteroids like prednisone or prednisolone are the mainstay of treatment for AIP. These drugs suppress inflammation and the excessive immune response. The majority of patients may experience rapid improvement, often within weeks of receiving therapy.
Treatment begins with an initial high dose of steroids, which is progressively tapered over weeks or months to avoid side effects. Patients are closely monitored during this time for signs of improvement and potential complications.
In a few individuals, AIP can spontaneously resolve without any form of therapy. Most, however, need medical treatment in order to manage inflammation and avoid complications like pancreatic injury or blockage of the bile duct.
In patients with obstructive jaundice, biliary stenting may be considered to relieve symptoms and aid diagnosis, especially when steroid therapy is delayed or diagnosis is unclear. This is referred to as biliary stenting and is particularly helpful if the diagnosis cannot be made or in severe cases of symptoms.
When a stent is placed, medical professionals can also take a sample of bile duct tissue or cells for analysis in a laboratory. This aids in confirming the diagnosis and excluding other conditions like cancer or primary sclerosing cholangitis.
For patients who relapse or cannot tolerate long-term steroids, immunosuppressive drugs such as azathioprine or mycophenolate may be used. Rituximab is considered in refractory or IgG4-related AIP. These promote remission maintenance and minimise the need for continued steroid use.
Autoimmune pancreatitis is an uncommon yet severe condition requiring adequate diagnosis and treatment. For people living in Jaipur, early identification, on-time treatment, and effective health planning can help manage the condition and lead a healthier life.